Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Receives US Army Grant to Develop Microarrays as Biowarfare Detection Systems

Premium

Nanogen has been awarded a three-year, $1.5 million grant from the US Army to continue developing NanoChip applications for detecting biological warfare agents and infectious disease agents.

This award, a ëDual Use Science and Technology’ grant, is the second that the San Diego microarray company has received from the Army. In October 2000, Nanogen received the first grant for biowarfare detection.

The research will be supervised by the US Army Medical Research Institute of Infectious Disease at Fort Detrick, Md.

NanoChip electronic microarrays use a matrix of 100 positively charged pads to immobilize strands of negatively charged DNA, enabling researchers to individually control hybridization sites.

In this project, the company is combining this technology with automated biological sample preparation and amplification steps. The finished product would be able to detect a biowarfare or infectious agent from a whole blood sample.

The company plans to use the technologies it develops under this grant to its development projects for molecular diagnostics.

This award comes just a week after Nanogen announced it had sold 10 new NanoChip workstations during the third quarter.

-MMJ


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.